Christadoss P - Search Results

1

Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis.

Tüzün E, Scott BG, Goluszko E, Higgs S, Christadoss P. Tüzün E, et al. Among authors: christadoss p. J Immunol. 2003 Oct 1;171(7):3847-54. doi: 10.4049/jimmunol.171.7.3847. J Immunol. 2003. PMID: 14500686

2

Tumor necrosis factor receptor p55 and p75 deficiency protects mice from developing experimental autoimmune myasthenia gravis.

Goluszko E, Deng C, Poussin MA, Christadoss P. Goluszko E, et al. Among authors: christadoss p. J Neuroimmunol. 2002 Jan;122(1-2):85-93. doi: 10.1016/s0165-5728(01)00474-x. J Neuroimmunol. 2002. PMID: 11777546

3

Treatment of experimental autoimmune myasthenia gravis with recombinant human tumor necrosis factor receptor Fc protein.

Christadoss P, Goluszko E. Christadoss P, et al. J Neuroimmunol. 2002 Jan;122(1-2):186-90. doi: 10.1016/s0165-5728(01)00473-8. J Neuroimmunol. 2002. PMID: 11777558

4

Role of IL-5 during primary and secondary immune response to acetylcholine receptor.

Poussin MA, Goluszko E, Franco JU, Christadoss P. Poussin MA, et al. Among authors: christadoss p. J Neuroimmunol. 2002 Apr;125(1-2):51-8. doi: 10.1016/s0165-5728(02)00030-9. J Neuroimmunol. 2002. PMID: 11960640

5

Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production.

Deng C, Goluszko E, Tüzün E, Yang H, Christadoss P. Deng C, et al. Among authors: christadoss p. J Immunol. 2002 Jul 15;169(2):1077-83. doi: 10.4049/jimmunol.169.2.1077. J Immunol. 2002. PMID: 12097416

6

B7-1 costimulatory molecule is critical for the development of experimental autoimmune myasthenia gravis.

Poussin MA, Tüzün E, Goluszko E, Scott BG, Yang H, Franco JU, Christadoss P. Poussin MA, et al. Among authors: christadoss p. J Immunol. 2003 Apr 15;170(8):4389-96. doi: 10.4049/jimmunol.170.8.4389. J Immunol. 2003. PMID: 12682276

7

Induction of myasthenia gravis in HLA transgenic mice by immunization with human acetylcholine receptors.

Yang H, Goluszko E, David C, Okita DK, Conti-Fine B, Chan TS, Poussin MA, Christadoss P. Yang H, et al. Among authors: christadoss p. Ann N Y Acad Sci. 2003 Sep;998:375-8. doi: 10.1196/annals.1254.044. Ann N Y Acad Sci. 2003. PMID: 14592899

8

Circulating immune complexes augment severity of antibody-mediated myasthenia gravis in hypogammaglobulinemic RIIIS/J mice.

Tüzün E, Scott BG, Yang H, Wu B, Goluszko E, Guigneaux M, Higgs S, Christadoss P. Tüzün E, et al. Among authors: christadoss p. J Immunol. 2004 May 1;172(9):5743-52. doi: 10.4049/jimmunol.172.9.5743. J Immunol. 2004. PMID: 15100321

9

ICOS is essential for the development of experimental autoimmune myasthenia gravis.

Scott BG, Yang H, Tüzün E, Dong C, Flavell RA, Christadoss P. Scott BG, et al. Among authors: christadoss p. J Neuroimmunol. 2004 Aug;153(1-2):16-25. doi: 10.1016/j.jneuroim.2004.04.019. J Neuroimmunol. 2004. PMID: 15265659

10

Cathepsin S is required for murine autoimmune myasthenia gravis pathogenesis.

Yang H, Kala M, Scott BG, Goluszko E, Chapman HA, Christadoss P. Yang H, et al. Among authors: christadoss p. J Immunol. 2005 Feb 1;174(3):1729-37. doi: 10.4049/jimmunol.174.3.1729. J Immunol. 2005. PMID: 15661938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters